RemeGen Stock

Detail Data
Volume (24h): 9,768,194 shares
P/E Ratio: /
Forward P/E: -29.87
EPS: -2.98 HKD
Forward EPS: -1.98 HKD
Number of Shares: 208,580,992 shares
Market Capitalization: 39,680,483,328.00 HKD

Dividend

Dividend Value
Dividend Amount According to our data, the company RemeGen does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a buy recommendation for RemeGen stock. The current number of analysts covering this company is 15. The highest target price is 66.989105 HKD, while the lowest target price is 16.30945 HKD. The median target valuation set by analysts is 34.79437 HKD. These forecasts and recommendations provide insight into how analysts view the future stock performance of RemeGen.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for RemeGen stock is: buy
Number of Analysts: 15
Highest Target Price: 66.989105 HKD
Lowest Target Price: 16.30945 HKD
Median Target Price: 34.79437 HKD

Fundamental Indicators

Indicator Data
Total Revenue: 1,912,395,520.00 HKD
Net Income: -1,373,583,616.00 HKD
Price-to-Book (P/B): 18.45
PEG Ratio: /
Exchange: HKSE
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 2999
Country: China

Where to Buy RemeGen Stock?

You can purchase RemeGen stock on the HKSE under the ticker symbol: 9995.HK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on RemeGen Stock

Indicator Value
Company Revenue: 1,912,395,520.00 HKD
EBITDA: -1,072,656,064.00 HKD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -2.98 HKD
Book Value Per Share: 3.21 HKD
Total Cash: 721,718,272.00 HKD
Total Cash per Share: 1.31 HKD
Total Debt: 2,729,039,872.00 HKD
Debt to Equity Ratio: 1.54
Quick Ratio 0.56
Current Ratio 0.92
Free Cash Flow -510,071,360.00 HKD
Operating Cash Flow -876,328,704.00 HKD
Gross Margins 81.15 %
EBITDA Margins -56.09 %
Operating Margins -43.15 %
Profit Margins -71.83 %
Return on Assets -15.3 %
Return on Equity -56.6 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 59.2 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 39,680,483,328.00 HKD
Enterprise Value 32,670,404,608.00 HKD
EV/Revenue 17.083
EV/EBITDA -30.457
Float Shares 327,183,379 shares
Shares Outstanding 208,580,992 shares
Held Percent Insiders 0.12 %
Held Percent Institutions 28.52 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.67
Short Percentage of Float -
Implied Shares Outstanding 670,844,992

Frequently Asked Questions (FAQ)

According to our data, the company RemeGen does not pay dividends yet, even in 2025.

RemeGen shares are traded on the HKSE stock exchange under the ticker: 9995.HK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for RemeGen shares is from a total of 15 analysts. The average target price prediction is 34.79437 HKD per share.

The total number of RemeGen shares on the exchange is 208,580,992.00 shares, which at the current market capitalization gives the company a total valuation of 39,680,483,328.00 HKD.